Mechanisms of Resistance and Implications for Treatment Strategies in Chronic Myeloid Leukaemia

SIMPLE SUMMARY: Chronic myeloid leukaemia (CML) is a type of blood cancer that is currently well-managed with drugs that target cancer-causing proteins. However, a significant proportion of CML patients do not respond to those drug treatments or relapse when they stop those drugs because the cancer...

Descripción completa

Detalles Bibliográficos
Autores principales: Poudel, Govinda, Tolland, Molly G., Hughes, Timothy P., Pagani, Ilaria S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9317051/
https://www.ncbi.nlm.nih.gov/pubmed/35884363
http://dx.doi.org/10.3390/cancers14143300

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9317051/
https://www.ncbi.nlm.nih.gov/pubmed/35884363
http://dx.doi.org/10.3390/cancers14143300

Ejemplares similares